The increase in the level CD1a+ dendritic cells at the TDLN provides evidence that dendritic cell maturation is inhibited at the lymph node by tumor-derived growth factors, such as prostaglandin-E2 (PGE2), TGF-β, IL-6, and VEGF [128, 132–136]. This evidence concerns the gene VEGFA and neoplasm.